NOT KNOWN DETAILS ABOUT SITUS JUDI MBL77

Not all people with CLL demand therapy. Even with all the latest advances, the iwCLL however recommends watchful observation for patients with asymptomatic disorder.86 This advice is based on not less than two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Eac